文献库搜索 | GeneLibs

Ullah(E),Abdel-Razeq(H),Bentebbal(S),Shaar... NPJ Breast Cancer 2026-03-19

...BRCA1/2 mutation prevalence suggest the presence of additional genetic risk factors across MENA subgroups. We analyzed w...

El Hejjioui(B),Bouramtane(A),Bouguenouch(L... BMC Med Genomics 2026-03-19

...BRCA1 and BRCA2 genes. Furthermore, the BRCA1 gene was mutated in 45% of patients with triple-negative breast cancer, hi...

Carmona(A),Gutierrez(N),Rubio(J),Castro(P)... BMC Plant Biol 2026-03-18

...BRCA1-related protein with potential roles in chromatin remodeling. In RIP12, LOC101495197 (MOS14), a nuclear import fac...

Shamana(K),Edwin(R),Jaishree(SP),Prashanth... In Silico Pharmacol None

...BRCA1, and EXO1. The supplementation of Phytocee™ resulted in further increases in these genes, reaching a log2 fold cha...

Xiao(JJ),Li(Y),Yang(L),Chen(HM),Hu(JW),Hu(... FASEB J 2026-03-31

...BRCA1-associated protein 1 (BAP1) through the N-terminal residues 1-29. The binding reduces the stability of the LKB1-MO...

Yamazawa(K),Ueki(A),Kuga(A),Hinoi(T),Niits... J Med Genet 2026-05-25

...BRCA1/2 genetic testing serves as a companion diagnostic for poly (ADP-ribose) polymerase inhibitor therapy in Japan, un...

Xie(Y),Chen(Q),Tang(N),Zeng(Y),Zhao(J),Yan... Cell Death Discov 2026-03-19

...BRCA1 mRNA, thus activating HR repair mediated by RAD51. Importantly, BRCA1 knockdown attenuated SERBP1-driven cisplatin...

Negri(S),Fornari(C),Ye(L),Inzoli(A),Costa(... Eur J Health Econ 2026-03-21

...BRCA1/2 PV carriers. METHODS: The developed Markov decision model simulated the progression of breast cancer and OC in B...

Shimizu(Y),Kitai(M),Akada(M),Maeda(M),Yama... Hered Cancer Clin Pract 2026-03-21

...BRCA1 variants were identified in 48 patients (34.5%), BRCA2 variants in 90 (64.7%), and both BRCA1 and BRCA2 variants i...

Faria(SS),Costantini(S),Di Gennaro(E),de L... Sci Rep 2026-03-21

Triple-negative breast cancer (TNBC) is an aggressive and immunogenic breast cancer subtype frequently associated with B...